Drug shortage
Amantadine Hydrochloride Capsule · Strides Pharma Inc.
FDA drug shortage · To Be Discontinued · updated Feb 12, 2025
Key facts
| Generic name | Amantadine Hydrochloride Capsule |
|---|---|
| Proprietary name | Amantadine Hydrochloride |
| Company | Strides Pharma Inc. |
| Presentation | Amantadine Hydrochloride, Capsule, 100 mg (NDC 42543-493-05) |
| Dosage form | Capsule |
| Strength | 100 mg |
| Status | To Be Discontinued |
| Therapeutic category | Antiviral Neurology |
| Package NDCs | 42543-493-05 |
| First posted | Feb 12, 2025 |
| Last updated | Feb 12, 2025 |
| Discontinued | Feb 12, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: